Solvotrin Therapeutics Competitors and Similar CompaniesClear all

Solvotrin Therapeutics's competitors and similar companies include Biogen and Cipla.
Solvotrin Therapeutics
Solvotrin Therapeutics
Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs.
Biogen
Biogen
Biogen is a biotechnology company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Cipla
Cipla
Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases.
Founding Date
Founding Date
2009
Founding Date
1978
Founding Date
1935
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
IE HQ
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paul, BR
Toronto, CA
see more
Locations
Mumbai, IN HQ
South Melbourne, AU
Mumbai, IN
Nairobi, KE
Cape Town, ZA
Durban, ZA
Durban, ZA
see more
Employees
Employees
19
Employees
9,6106% increase
Employees
26,61516% increase
Twitter followers
Twitter followers
N/A
Twitter followers
45.7 k
Twitter followers
33.9 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
41
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.6
Average likes per tweet (last 30 days)
2.9
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
95%
Percentage of tweets with engagement (last 30 days)
65.85%
Employee Rating
Employee Rating
5
Employee Rating
4
Employee Rating
3.9

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$9.8b (FY, 2023)
Revenue (est.)
₹224.7b (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
$2.5b (FY, 2023)
Cost of goods
₹82.5b (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
$7.3b (FY, 2023)
Gross profit
₹145b (FY, 2023)
Net income
Net income
N/A
Net income
$1.2b (FY, 2023)
Net income
₹28.4b (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Biogen
HQ
Cambridge, US
Employees
9,610↑ 6% increase

Biogen is a biotechnology company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Cipla
HQ
Mumbai, IN
Employees
26,615↑ 16% increase

Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases.

View company